Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure identifies Investec Bank plc as an exempt principal trader acting in a client-serving capacity with recognised intermediary status under the Takeover Code.
Investec holds a dual role in relation to this transaction, serving as both advisor and joint broker to Advanced Medical Solutions Group Plc.
The dealings reported in the disclosure were undertaken on 14th July 2026, with the formal disclosure date recorded as 15th July 2026.
According to the filing, Investec purchased a total of 375,000 ordinary shares in Advanced Medical Solutions Group at a price of 278.5 pence per unit.
On the selling side, Investec disposed of 519,417 ordinary shares, with prices ranging between 278.5 and 279.5 pence per unit.
The volume of sales exceeded purchases in this round of dealing, with Investec selling over 144,000 more shares than it bought on the day.
The filing confirms there were no cash-settled derivative transactions, stock-settled derivative transactions, or options exercised as part of these dealings.
Investec also confirmed there are no indemnity arrangements, options, or other agreements that could serve as an inducement to deal or refrain from dealing with any party to the offer.
Similarly, no agreements or understandings exist between Investec and any other person regarding voting rights or future acquisition or disposal of relevant securities referenced by any derivative.
The contact listed for this disclosure is Abhishek Gawde, reachable by telephone, with the filing submitted in compliance with public disclosure obligations under Rule 8 of the Takeover Code.
Rule 8.5 disclosures are required to be made to a Regulatory Information Service and are monitored by the Panel’s Market Surveillance Unit to ensure transparency during offer periods.
